Latest News for: the spine journal

Edit

NuVasive's X360 Procedural Approach Validated in Clinical Study Published in The Spine Journal Finding Single-Position Spine Surgery Improves Operative Efficiency While Reducing Complications and Length of Hospital Stay

PR Newswire 06 Jan 2021
... fusion improves operative efficiency, reduces complications and length of stay compared with traditional circumferential fusion," in The Spine Journal, validating single-position spine surgery as having significant advantages over traditional, open spinal fusion.
Edit

NuVasive’s X360 Procedural Approach Validated in Clinical Study Published in The Spine Journal Finding Single-Position Spine Surgery Improves Operative Efficiency While Reducing Complications and Length of Hospital Stay (NuVasive Inc)

Public Technologies 06 Jan 2021
... circumferential fusion improves operative efficiency, reduces complications and length of stay compared with traditional circumferential fusion,' in The Spine Journal, validating single-position spine surgery as having significant advantages over traditional, open spinal fusion.
Edit

RTI Surgical® Announces The Spine Journal’s Publication of In Vivo TETRAfuse® 3D Technology PEKK Study

Dothan Eagle 17 Dec 2019
A TETRAfuse® PEKK Study” in The Spine Journal1 ... “The data from this hallmark ovine study in The Spine Journal indicate TETRAfuse 3D Technology’s unique potential to improve the effectiveness of spinal fusion procedures,” said Camille Farhat, President and CEO, RTI Surgical ... The Spine Journal.
Edit

Stryker announces SAKOS pivotal trial results for SpineJack System published in The Spine Journal

PR Newswire 25 Sep 2019
25, 2019 /PRNewswire/ -- Stryker announced today the publication of the SAKOS pivotal trial results for the SpineJack implantable fracture reduction system (SpineJack System) in The Spine Journal.1 The SAKOS trial was a prospective, multicenter, randomized study designed to ...
Edit

DiscGenics Announces Publication of Preclinical Data for Disc Degeneration Treatment in The Spine Journal

The Daily Times 24 Sep 2019
SALT LAKE CITY, Sept. 24, 2019 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the online publication ... .
  • 1
×